Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammasomes | 6 | 2026 | 352 | 2.640 |
Why?
|
| Nucleotidyltransferases | 6 | 2026 | 66 | 2.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2024 | 345 | 1.920 |
Why?
|
| Phosphate-Binding Proteins | 3 | 2024 | 20 | 1.660 |
Why?
|
| Pyroptosis | 5 | 2026 | 38 | 1.400 |
Why?
|
| Interferon Type I | 2 | 2023 | 198 | 1.250 |
Why?
|
| Interferons | 2 | 2025 | 74 | 1.050 |
Why?
|
| Pyrin | 1 | 2026 | 8 | 0.980 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2026 | 23 | 0.970 |
Why?
|
| Cell Membrane | 2 | 2026 | 506 | 0.970 |
Why?
|
| Nerve Growth Factors | 1 | 2026 | 28 | 0.930 |
Why?
|
| Membrane Proteins | 4 | 2026 | 925 | 0.930 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2026 | 24 | 0.920 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2025 | 9 | 0.900 |
Why?
|
| Microscopy | 1 | 2026 | 99 | 0.900 |
Why?
|
| Macrophages | 3 | 2026 | 1041 | 0.870 |
Why?
|
| Cell Death | 1 | 2026 | 289 | 0.850 |
Why?
|
| Lipoylation | 1 | 2024 | 5 | 0.840 |
Why?
|
| Carcinogenesis | 2 | 2024 | 135 | 0.830 |
Why?
|
| Immunity | 1 | 2024 | 107 | 0.800 |
Why?
|
| Signal Transduction | 5 | 2025 | 3162 | 0.770 |
Why?
|
| Animals | 20 | 2026 | 21459 | 0.770 |
Why?
|
| Interleukin-1beta | 2 | 2021 | 274 | 0.750 |
Why?
|
| Dimethyl Fumarate | 1 | 2020 | 8 | 0.650 |
Why?
|
| Familial Mediterranean Fever | 1 | 2020 | 9 | 0.650 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2020 | 60 | 0.630 |
Why?
|
| Cysteine | 1 | 2020 | 108 | 0.620 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2019 | 10 | 0.610 |
Why?
|
| Inflammation | 3 | 2025 | 1195 | 0.600 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 239 | 0.590 |
Why?
|
| Neutrophils | 1 | 2021 | 396 | 0.550 |
Why?
|
| Multiple Sclerosis | 1 | 2020 | 227 | 0.530 |
Why?
|
| Histones | 1 | 2020 | 497 | 0.510 |
Why?
|
| Immunity, Innate | 4 | 2024 | 829 | 0.480 |
Why?
|
| Apoptosis | 3 | 2026 | 1100 | 0.470 |
Why?
|
| Mice | 12 | 2026 | 11173 | 0.460 |
Why?
|
| Humans | 20 | 2026 | 65645 | 0.440 |
Why?
|
| Single-Domain Antibodies | 2 | 2026 | 21 | 0.410 |
Why?
|
| Neoplasms | 1 | 2024 | 1376 | 0.410 |
Why?
|
| Immunoglobulin A | 2 | 2026 | 102 | 0.390 |
Why?
|
| Colitis | 2 | 2023 | 80 | 0.340 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2021 | 263 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 3500 | 0.250 |
Why?
|
| Cell Nucleus | 2 | 2020 | 634 | 0.240 |
Why?
|
| Cell Membrane Permeability | 1 | 2026 | 40 | 0.240 |
Why?
|
| Alkynes | 1 | 2026 | 28 | 0.240 |
Why?
|
| Amides | 1 | 2026 | 60 | 0.230 |
Why?
|
| Nucleotides, Cyclic | 1 | 2025 | 16 | 0.230 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2026 | 50 | 0.220 |
Why?
|
| Triazoles | 1 | 2025 | 63 | 0.220 |
Why?
|
| Microscopy, Confocal | 1 | 2026 | 240 | 0.220 |
Why?
|
| Mutation | 2 | 2025 | 2670 | 0.220 |
Why?
|
| Herpesvirus 1, Human | 1 | 2025 | 83 | 0.210 |
Why?
|
| Kinetics | 1 | 2026 | 757 | 0.210 |
Why?
|
| Antibodies, Neutralizing | 1 | 2026 | 218 | 0.200 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2026 | 503 | 0.200 |
Why?
|
| Mitochondria | 2 | 2024 | 413 | 0.200 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2023 | 13 | 0.200 |
Why?
|
| Lysosomes | 1 | 2024 | 175 | 0.200 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2024 | 132 | 0.200 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 237 | 0.200 |
Why?
|
| Virus Diseases | 1 | 2024 | 117 | 0.190 |
Why?
|
| Protein Binding | 1 | 2026 | 1633 | 0.180 |
Why?
|
| NF-kappa B | 1 | 2023 | 435 | 0.170 |
Why?
|
| Interleukin-18 | 1 | 2021 | 75 | 0.170 |
Why?
|
| RNA, Long Noncoding | 1 | 2023 | 170 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 441 | 0.160 |
Why?
|
| Ubiquitination | 1 | 2021 | 124 | 0.160 |
Why?
|
| Thrombosis | 1 | 2023 | 207 | 0.160 |
Why?
|
| Myeloid Cells | 1 | 2021 | 98 | 0.160 |
Why?
|
| Citric Acid Cycle | 1 | 2020 | 29 | 0.160 |
Why?
|
| Dysbiosis | 1 | 2021 | 74 | 0.160 |
Why?
|
| RNA Precursors | 1 | 2020 | 80 | 0.160 |
Why?
|
| Macrophage Activation | 1 | 2020 | 115 | 0.160 |
Why?
|
| Mice, Mutant Strains | 1 | 2020 | 301 | 0.150 |
Why?
|
| Drosophila | 1 | 2023 | 479 | 0.150 |
Why?
|
| NLR Proteins | 1 | 2019 | 11 | 0.150 |
Why?
|
| DNA Viruses | 1 | 2019 | 16 | 0.150 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2024 | 448 | 0.150 |
Why?
|
| Caspases | 1 | 2020 | 176 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 679 | 0.150 |
Why?
|
| Caspase 1 | 1 | 2019 | 115 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 152 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 269 | 0.140 |
Why?
|
| DNA | 1 | 2023 | 853 | 0.140 |
Why?
|
| HEK293 Cells | 1 | 2020 | 617 | 0.140 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2023 | 517 | 0.140 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 625 | 0.130 |
Why?
|
| Caenorhabditis elegans | 1 | 2024 | 708 | 0.130 |
Why?
|
| Structure-Activity Relationship | 2 | 2026 | 355 | 0.110 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2026 | 114 | 0.100 |
Why?
|
| Antibodies, Viral | 2 | 2026 | 327 | 0.090 |
Why?
|
| Intestinal Mucosa | 2 | 2024 | 253 | 0.090 |
Why?
|
| Intestines | 2 | 2024 | 184 | 0.090 |
Why?
|
| Camelids, New World | 1 | 2026 | 10 | 0.060 |
Why?
|
| Protein Engineering | 1 | 2026 | 85 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2025 | 315 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2024 | 149 | 0.050 |
Why?
|
| Pseudomonas Infections | 1 | 2024 | 73 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 34 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2025 | 858 | 0.050 |
Why?
|
| Cyclic GMP | 1 | 2023 | 33 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2024 | 139 | 0.050 |
Why?
|
| Platelet Activation | 1 | 2023 | 31 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2024 | 205 | 0.050 |
Why?
|
| Male | 2 | 2021 | 31292 | 0.050 |
Why?
|
| Proteome | 1 | 2023 | 153 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2023 | 266 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2023 | 108 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2024 | 279 | 0.040 |
Why?
|
| Virus Replication | 1 | 2023 | 323 | 0.040 |
Why?
|
| Female | 2 | 2021 | 34309 | 0.040 |
Why?
|
| Epitopes | 1 | 2022 | 291 | 0.040 |
Why?
|
| Oligonucleotides | 1 | 2023 | 229 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2024 | 689 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 383 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 472 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2023 | 328 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2023 | 446 | 0.040 |
Why?
|
| Monocytes | 1 | 2021 | 361 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1144 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 969 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2023 | 987 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2023 | 1559 | 0.030 |
Why?
|